CRISPR-Cas9 (N-Term) antibody
Quick Overview for CRISPR-Cas9 (N-Term) antibody (ABIN5563966)
Target
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- N-Term
-
Purpose
- SaCas9 antibody (mAb) (Clone 11E7)
-
Purification
- Protein A Chromatography
-
Immunogen
- This antibody was raised against a recombinant protein within the N-terminal region of Staphylococcus aureus Cas9. This antibody should recognize Cas9 and dCas9 based on the antigen design.
-
Isotype
- IgG2a
-
-
-
-
Application Notes
- WB: 0.5 - 2 μg/mL This antibody is also available as an AbFlex engineered recombinant antibody. For details on the corresponding AbFlex Recombinant Antibody, see Catalog No. 91279.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified IgG in PBS with 30 % glycerol and 0.035 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze/thaw cycles by aliquoting items into single-use fractions,Keep all reagents on ice when not in storage
-
Storage
- -20 °C
-
Storage Comment
- Some products may be shipped at room temperature. This will not affect their stability or performance. Avoid repeated freeze/thaw cycles by aliquoting items into single-use fractions for storage at -20°C for up to 2 years. Keep all reagents on ice when not in storage.
-
Expiry Date
- 24 months
-
-
- CRISPR-Cas9
-
Alternative Name
- Cas9
-
Background
- SaCas9 is a nuclease from Staphylococcus aureus that can be targeted to particular DNA sequences through a guide RNA that results in double-stranded breaks in DNA. Cas9 is part of the CRISPR/Cas9 gene-editing system that can create a DNA break at a specific location with the genome. CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA) Probable. In type II CRISPR systems correct processing of pre-crRNA requires a trans-encoded small RNA (tracrRNA), endogenous ribonuclease 3 (rnc) and this protein. The tracrRNA serves as a guide for ribonuclease 3-aided processing of pre-crRNA. Subsequently Cas9/crRNA/tracrRNA endonucleolytically cleaves linear or circular dsDNA target complementary to the spacer. The target strand not complementary to crRNA is first cut endonucleolytically, then trimmed by 3'-5' exonucleolytically. DNA-binding requires protein and both RNA species. Cas9 probably recognizes a short motif in the CRISPR repeat sequences (the PAM or protospacer adjacent motif) to help distinguish self versus nonself.
-
Molecular Weight
- 130 kDa
Target
-